Browse Studies — Arctuva

Observational

Aromatherapy Inhaler Use for Hematopoietic Stem Cell Transplant Patient Distress

This randomized controlled trial will evaluate the feasibility and acceptability of an inhaled aromatherapy stick for patients during the acute inpatient phase…

Cancer DistressCancer CopingHematopoetic Stem Cell Transplant+1 more

Estimated

~$10 – $6,250

Stanford UniversityNCT05302583

Phase 1

Exercise-induced Adrenergic Receptor Signaling as an Immune Adjuvant for Allogeneic Cell Therapies

This study aims to improve the treatment of blood cancer by using exercise to collect healthier immune cells from donors. Allogeneic adoptive cell therapy is a…

LeukemiaHematopoetic Stem Cell TransplantationDonor Lymphocyte Infusion+3 more

Estimated

~$10 – $6,250

University of ArizonaNCT06643221

Phase 1

Ruxolitinib-Enhanced Conditioning for Pediatric and Young Adult Patients With Symptomatic Sickle Cell Disease Undergoing Haploidentical Hematopoietic Cell Transplantation

This trial will determine whether adding ruxolitinib to a reduced intensity conditioning (RIC) regimen reduces the rate of graft failure following haploidentic…

Sickle Cell DiseaseHematopoetic Stem Cell TransplantHaploidentical Hematopoietic Stem Cell Transplant+2 more

Estimated

~$10 – $6,250

Arkansas Children's Hospital Research InstituteNCT07252050

Observational

Adapting After Discharge From Allogeneic SCT: Partnering Together; Dyadic Intervention to Improve Patient-Family Caregiver Team-Based Management of the Medical Regimen After Allogeneic Hematopoietic Cell Transplantation

Adherence to the medical regimen after stem cell transplant is challenging for both patients and their family caregivers. The investigators propose a randomize…

Stem Cell TransplantHematopoetic Stem Cell TransplantHematopoetic Stem Cell Transplantation

Estimated

~$10 – $6,250

University of PittsburghNCT07107165